S&P 500

5.321,41

0,00%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ACLA

Aclara Biosciences (ACLA)

Aclara Biosciences, (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACLA

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
10/12/2004	19h31	PR Newswire (US)	ViroLogic and ACLARA Announce Stockholder Approval of Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
02/12/2004	15h00	PR Newswire (US)	Iceland Genomics Corporation and ACLARA Collaborating on Cancer Biomarkers	NASDAQ:ACLA	Aclara Biosciences, (MM)
09/11/2004	13h45	PR Newswire (US)	ACLARA Announces Third Quarter 2004 Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
08/11/2004	13h00	PR Newswire (US)	ViroLogic and ACLARA to Mail Revised Definitive Proxy for Proposed Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
04/11/2004	13h45	PR Newswire (US)	Clinical Data Presented at ESMO Shows ETAG(TM) System's Potential in Predicting Response to Cancer Treatment	NASDAQ:ACLA	Aclara Biosciences, (MM)
27/10/2004	15h01	PR Newswire (US)	Manuel Hidalgo, M.D., Ph.D., Joins ACLARA BioSciences Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
19/10/2004	14h00	PR Newswire (US)	ViroLogic and ACLARA BioSciences Revise Merger Terms	NASDAQ:ACLA	Aclara Biosciences, (MM)
05/10/2004	14h45	PR Newswire (US)	ACLARA and GlaxoSmithKline Evaluating eTag(TM) Technology for Patient Selection for Targeted Cancer Therapies	NASDAQ:ACLA	Aclara Biosciences, (MM)
30/09/2004	14h45	PR Newswire (US)	ACLARA Data at EORTC-NCI-AACR Symposium Demonstrates ETAG(TM) System Potential in Cancer Drug Development and Treatment Prognosi	NASDAQ:ACLA	Aclara Biosciences, (MM)
29/09/2004	00h04	PR Newswire (US)	ViroLogic and ACLARA Mail Definitive Proxy for Proposed Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
04/08/2004	23h30	PR Newswire (US)	Aclara Announces Second Quarter Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
07/07/2004	14h00	PR Newswire (US)	ACLARA BioSciences Appoints Roy S. Herbst, M.D., Ph.D., To Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
14/06/2004	14h45	PR Newswire (US)	ACLARA BioSciences and Tokyo Metropolitan Institute of Medical Science (Rinshoken) to Conduct Breast Cancer Biomarker Study	NASDAQ:ACLA	Aclara Biosciences, (MM)
11/06/2004	02h11	PR Newswire (US)	Aclara to Present at Needham Third Annual Biotechnology Conference	NASDAQ:ACLA	Aclara Biosciences, (MM)
10/06/2004	14h45	PR Newswire (US)	Prominent Oncologist Appointed to ACLARA Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
03/06/2004	15h00	PR Newswire (US)	ACLARA to Host Investor Briefing and Webcast at ASCO Annual Meeting Monday June 7, 2004 at 7:00 A.M. Central time	NASDAQ:ACLA	Aclara Biosciences, (MM)
02/06/2004	23h20	PR Newswire (US)	ACLARA eTag Technology to be Discussed at ASCO Annual Meeting	NASDAQ:ACLA	Aclara Biosciences, (MM)
01/06/2004	14h30	PR Newswire (US)	ViroLogic and ACLARA BioSciences Announce Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
29/04/2004	15h30	PR Newswire (US)	ACLARA Announces First Quarter Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
05/04/2004	15h30	PR Newswire (US)	ACLARA Receives Four U.S. Patents for Its eTag(TM) and Nanofluidic Technologies	NASDAQ:ACLA	Aclara Biosciences, (MM)
11/12/2003	14h00	PR Newswire (US)	John Weinstein, M.D. Ph.D. Appointed to ACLARA Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
04/12/2003	14h30	PR Newswire (US)	ACLARA and Cell Signaling Technology, Inc. Enter into Antibody Supply Agreement	NASDAQ:ACLA	Aclara Biosciences, (MM)
05/11/2003	22h00	PR Newswire (US)	ACLARA Announces Third Quarter 2003 Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
29/10/2003	20h00	PR Newswire (US)	ADVISORY: ACLARA BioSciences, Inc. to Announce Q3 2003 Financial Results On November 5, 2003	NASDAQ:ACLA	Aclara Biosciences, (MM)